West Pharmaceutical Services Inc. has witnessed a significant turn of events. Key stakeholders have adjusted their investment positions, with
Findlay Park Partners LLP maintaining a hefty $210.42 million stake and
Citigroup Inc. owning a sizable $21.71 million stake. Concurrently,
TD Asset Management Inc. and
Vanguard Group Inc hold $159.06 million and own 388,144 shares respectively. Other noteworthy shifts include
Generation Investment Management LLP selling 189,763 shares and
Assetmark Inc. selling 26,486 shares.
West Pharmaceutical Services' stocks surged 5.5% on record earnings and received strong backing from hedge funds showing robust financial performance. The company issued a US$1 billion buyback and dividend increase, bolstering its reputation as a top momentum stock. After reporting successful Q4 CY2025 results and skyrocketing sales, analysts predict a potent 32.33% surge in West Pharmaceutical Services' stocks. Even amid sector pressure and a recent slight share price decline, experts recommend long-term investment. The company boasts strong 2025 results and a promising 2026 growth outlook.
West Pharmaceutical Services WST News Analytics from Mon, 21 Jul 2025 07:00:00 GMT to Sat, 28 Feb 2026 13:01:03 GMT -
